GOBBI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 120
EU - Europa 57
AS - Asia 45
AF - Africa 6
Totale 228
Nazione #
US - Stati Uniti d'America 120
SG - Singapore 21
DE - Germania 15
IT - Italia 14
GB - Regno Unito 12
IN - India 9
CN - Cina 8
SE - Svezia 6
IE - Irlanda 5
TG - Togo 5
ID - Indonesia 3
BG - Bulgaria 2
HK - Hong Kong 2
JO - Giordania 2
FI - Finlandia 1
FR - Francia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 228
Città #
Santa Clara 33
Singapore 20
Southend 11
Bologna 8
Princeton 8
Ashburn 7
Boardman 5
Chandler 5
Dublin 5
Fairfield 5
Houston 5
Lomé 5
Berlin 3
Jakarta 3
Redmond 3
Amman 2
Ann Arbor 2
Bühl 2
Chicago 2
Des Moines 2
Forlì 2
Hong Kong 2
Leawood 2
Olalla 2
Sofia 2
Cambridge 1
Casalecchio di Reno 1
Hebei 1
Jinan 1
Lappeenranta 1
Seattle 1
Shenzhen 1
Westminster 1
Wilmington 1
Woodbridge 1
Wuhan 1
Zibo 1
Totale 158
Nome #
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells 61
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma 58
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy 51
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer 48
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 32
Totale 250
Categoria #
all - tutte 1.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 3 1 1 1 0
2020/202119 2 1 1 1 1 0 0 5 4 0 0 4
2021/202249 1 0 4 0 4 2 0 10 12 1 9 6
2022/202362 4 8 4 4 2 12 5 6 10 2 0 5
2023/202429 2 2 2 3 1 3 0 1 2 1 9 3
2024/202585 1 29 6 8 40 1 0 0 0 0 0 0
Totale 250